These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 16138223

  • 1. High baseline serum total and LDL cholesterol levels are associated with MDR1 haplotypes in Brazilian hypercholesterolemic individuals of European descent.
    Rodrigues AC, Rebecchi IM, Bertolami MC, Faludi AA, Hirata MH, Hirata RD.
    Braz J Med Biol Res; 2005 Sep; 38(9):1389-97. PubMed ID: 16138223
    [Abstract] [Full Text] [Related]

  • 2. Do MDR1 and SLCO1B1 polymorphisms influence the therapeutic response to atorvastatin? A study on a cohort of Egyptian patients with hypercholesterolemia.
    Shabana MF, Mishriki AA, Issac MS, Bakhoum SW.
    Mol Diagn Ther; 2013 Oct; 17(5):299-309. PubMed ID: 23677857
    [Abstract] [Full Text] [Related]

  • 3. Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin.
    Cerda A, Genvigir FD, Arazi SS, Hirata MH, Dorea EL, Bernik MM, Bertolami MC, Faludi AA, Hirata RD.
    Clin Chim Acta; 2010 May 02; 411(9-10):631-7. PubMed ID: 20064494
    [Abstract] [Full Text] [Related]

  • 4. Effect of ABCB1 genotype on pre- and post-cardiac transplantation plasma lipid concentrations.
    Taegtmeyer AB, Breen JB, Smith J, Rogers P, Kullak-Ublick GA, Yacoub MH, Banner NR, Barton PJ.
    J Cardiovasc Transl Res; 2011 Jun 02; 4(3):304-12. PubMed ID: 21445698
    [Abstract] [Full Text] [Related]

  • 5. Polymorphisms in the multidrug resistance-1 (MDR1) gene influence the response to atorvastatin treatment in a gender-specific manner.
    Kajinami K, Brousseau ME, Ordovas JM, Schaefer EJ.
    Am J Cardiol; 2004 Apr 15; 93(8):1046-50. PubMed ID: 15081455
    [Abstract] [Full Text] [Related]

  • 6. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.
    Cascorbi I, Gerloff T, Johne A, Meisel C, Hoffmeyer S, Schwab M, Schaeffeler E, Eichelbaum M, Brinkmann U, Roots I.
    Clin Pharmacol Ther; 2001 Mar 15; 69(3):169-74. PubMed ID: 11240981
    [Abstract] [Full Text] [Related]

  • 7. Lack of association between SLCO1B1 polymorphism and the lipid-lowering effects of atorvastatin and simvastatin in Chinese individuals.
    Fu Q, Li YP, Gao Y, Yang SH, Lu PQ, Jia M, Zhang LR.
    Eur J Clin Pharmacol; 2013 Jun 15; 69(6):1269-74. PubMed ID: 23263738
    [Abstract] [Full Text] [Related]

  • 8. Frequency of common MDR1 gene variants in a Polish population.
    Kurzawski M, Pawlik A, Górnik W, Droździk M.
    Pharmacol Rep; 2006 Jun 15; 58(1):35-40. PubMed ID: 16531628
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation.
    Goto M, Masuda S, Saito H, Uemoto S, Kiuchi T, Tanaka K, Inui K.
    Pharmacogenetics; 2002 Aug 15; 12(6):451-7. PubMed ID: 12172213
    [Abstract] [Full Text] [Related]

  • 11. Frequency of G2677T/A and C3435T polymorphisms of MDR1 gene in preeclamptic women.
    Bogacz A, Mrozikiewicz PM, Deka-Pawlik D, Seremak-Mrozikiewicz A, Bartkowiak-Wieczorek J, Barlik M, Drews K, Kowalska A, Grześkowiak E.
    Ginekol Pol; 2013 Sep 15; 84(9):781-7. PubMed ID: 24191517
    [Abstract] [Full Text] [Related]

  • 12. No impact of SLCO1B1 521T>C, 388A>G and 411G>A polymorphisms on response to statin therapy in the Greek population.
    Giannakopoulou E, Ragia G, Kolovou V, Tavridou A, Tselepis AD, Elisaf M, Kolovou G, Manolopoulos VG.
    Mol Biol Rep; 2014 Jul 15; 41(7):4631-8. PubMed ID: 24668570
    [Abstract] [Full Text] [Related]

  • 13. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.
    Yi SY, Hong KS, Lim HS, Chung JY, Oh DS, Kim JR, Jung HR, Cho JY, Yu KS, Jang IJ, Shin SG.
    Clin Pharmacol Ther; 2004 Nov 15; 76(5):418-27. PubMed ID: 15536457
    [Abstract] [Full Text] [Related]

  • 14. Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups.
    Li D, Zhang GL, Lou YQ, Li Q, Wang X, Bu XY.
    J Clin Pharm Ther; 2007 Feb 15; 32(1):89-95. PubMed ID: 17286792
    [Abstract] [Full Text] [Related]

  • 15. Influence of SREBP-2 and SCAP gene polymorphisms on lipid-lowering response to atorvastatin in a cohort of Chilean subjects with Amerindian background.
    Lagos J, Zambrano T, Rosales A, Salazar LA.
    Mol Diagn Ther; 2014 Aug 15; 18(4):435-43. PubMed ID: 24615250
    [Abstract] [Full Text] [Related]

  • 16. Detection of C1236T, G2677T/A, and C3435T polymorphism of MDR1 by amplification refractory mutation system PCR.
    Chen B, Fang J, Zhang W, Jin Z, Yu Z, Cai W.
    J Clin Lab Anal; 2009 Aug 15; 23(2):110-6. PubMed ID: 19288456
    [Abstract] [Full Text] [Related]

  • 17. Identification of functionally variant MDR1 alleles among European Americans and African Americans.
    Kim RB, Leake BF, Choo EF, Dresser GK, Kubba SV, Schwarz UI, Taylor A, Xie HG, McKinsey J, Zhou S, Lan LB, Schuetz JD, Schuetz EG, Wilkinson GR.
    Clin Pharmacol Ther; 2001 Aug 15; 70(2):189-99. PubMed ID: 11503014
    [Abstract] [Full Text] [Related]

  • 18. Common variants of HMGCR, CETP, APOAI, ABCB1, CYP3A4, and CYP7A1 genes as predictors of lipid-lowering response to atorvastatin therapy.
    Poduri A, Khullar M, Bahl A, Sehrawat BS, Sharma Y, Talwar KK.
    DNA Cell Biol; 2010 Oct 15; 29(10):629-37. PubMed ID: 20578904
    [Abstract] [Full Text] [Related]

  • 19. Identification of pharmacogenetic predictors of lipid-lowering response to atorvastatin in Chilean subjects with hypercholesterolemia.
    Rosales A, Alvear M, Cuevas A, Saavedra N, Zambrano T, Salazar LA.
    Clin Chim Acta; 2012 Feb 18; 413(3-4):495-501. PubMed ID: 22120734
    [Abstract] [Full Text] [Related]

  • 20. CYP3A53A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia.
    Willrich MA, Hirata MH, Genvigir FD, Arazi SS, Rebecchi IM, Rodrigues AC, Bernik MM, Dorea EL, Bertolami MC, Faludi AA, Hirata RD.
    Clin Chim Acta; 2008 Dec 18; 398(1-2):15-20. PubMed ID: 18727922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.